Strategic therapeutic areas
Our in-house capabilities are focused around critical and differentiating areas such as target identification with a strong emphasis on human and clinical validation, translational science as well as disease understanding. Above and beyond these particularly critical success factors, we can cover every step in the development of an innovative medicine.
At the same time, we are committed to enter into strategic partnerships with innovative players from across industry and academia who share our passion to shape the field and foster the development of meaningful therapies. And alongside our pursuit of these four key areas, we’re also looking for partners who are eager to team up with us in the development of therapeutic solutions for patients with fibromyalgia, complex regional pain syndrome, migraine and peri-surgical pain.